Glial Fibrillary Acidic Protein Autoimmunity After Aseptic Meningitis: A Report of 2 Cases.


Journal

Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 16 06 2023
accepted: 21 09 2023
medline: 13 11 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

We describe 2 patients with glial fibrillary acidic protein (GFAP) autoimmunity secondary to aseptic viral meningitis or meningoencephalomyelitis. This study involved a retrospective chart review. Two female patients, 45 and 55 years of age, developed aseptic meningoencephalomyelitis or meningitis; in one patient, it was likely caused by herpes simplex virus 2. The patients were recovering from the infectious condition when they, 51 and 5 days after onset, had new symptoms with detection of GFAP antibodies in the CSF; CSF and serum samples from the initial lumbar punctures had been negative for GFAP antibodies. Both patients recovered with steroid treatment (in one case, plus rituximab; in the other, plus azathioprine) including resolution of MRI and CSF abnormalities. These 2 patients had GFAP autoimmunity secondary to viral meningoencephalomyelitis or meningitis. This suggests that GFAP astrocytopathy might not always be a primary disease entity; it may follow another brain injury that triggers this autoimmune response.

Identifiants

pubmed: 37949666
pii: 11/1/e200180
doi: 10.1212/NXI.0000000000200180
pmc: PMC10691222
pii:
doi:

Substances chimiques

Glial Fibrillary Acidic Protein 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Références

Clin Chem. 1991 Jul;37(7):1153-60
pubmed: 1855284
Ann Neurol. 2017 Feb;81(2):298-309
pubmed: 28120349
Neurology. 2015 Nov 17;85(20):1736-43
pubmed: 26491084
Mult Scler Relat Disord. 2018 Apr;21:84-87
pubmed: 29499442
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):138-146
pubmed: 28951498
JAMA Neurol. 2016 Nov 01;73(11):1297-1307
pubmed: 27618707
J Neurol. 2020 Jul;267(7):2101-2114
pubmed: 32246252
J Neuroimmunol. 2019 Jul 15;332:91-98
pubmed: 30991306
Curr Opin Neurol. 2019 Jun;32(3):452-458
pubmed: 30724768
Eur J Neurol. 2017 Jan;24(1):175-186
pubmed: 27786401
Neurology. 2020 Jun 2;94(22):e2302-e2310
pubmed: 32161029
J Neuroimmunol. 2018 Aug 15;321:157-163
pubmed: 29793728
Lancet Neurol. 2018 Sep;17(9):760-772
pubmed: 30049614
Neurology. 2022 Feb 8;98(6):e653-e668
pubmed: 34799461
Ann Neurol. 2014 Feb;75(2):317-23
pubmed: 24318406
Eur J Neurol. 2018 Mar;25(3):477-483
pubmed: 29193473

Auteurs

Christian G Bien (CG)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany. christian.bien@gmx.de.

Thomas Büttner (T)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Ina C Reichen (IC)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Annette Thomas (A)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Benjamin Vlad (B)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Friedrich Woermann (F)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Corinna I Bien (CI)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany. christian.bien@gmx.de.

Ilijas Jelcic (I)

From the Bielefeld University (C.G.B.); Klinikum Emden (T.B., A.T.), Germany; University Hospital Zurich and University of Zurich (I.C.R., B.V., I.J.), Switzerland; Laboratory Krone (C.I.B.), Bad Salzuflen; Krankenhaus Mara (F.W.), Bielefeld, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH